Orphazyme ApS, a Copenhagen, Denmark-based biopharmaceutical company that develops innovative medicines for the treatment of a family of genetic disorders called lysosomal storage diseases,...
Operator Systems, a Herlev, Denmark-based company that develops and implements a standard Manufacturing Execution System (MES) application, has received an equity investment of undisclosed...
Avanti Wind Systems, a Hillerød, Denmark-based company that develops and produces advanced lifts, ladders and safety systems used for service and maintenance of wind...
Private equity fund Axcel has agreed with EQT Opportunity, the founding family (Toftdahl Olesen), and the management to acquire Cimbria, a Thisted, Denmark-based manufacturer of equipment for...
B.V. Electronic (BVE), a Danish supplier of computer-based SCADA systems for process control and special software for the industry, has been acquired by Via...
HusCompagniet, a Denmark-based producer of single-family homes, has been acquired by private equity fund FSN Capital.The amount of the transaction remained undisclosed. FSN Capital...
Private equity firm GMT Communications Partners has agreed to acquire the legal and tax & accounting businesses of Thomson Reuters in Denmark and Sweden....
Orphazyme Aps, a Copenhagen, Denmark-based company that develops therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, raised...
Podio, a Copenhagen, Denmark-based company that operates a connected work platform allowing employees and professionals to work and interact, secured $4m in Series A...
EpiTherapeutics, a Copenhagen, Denmark-based biopharmaceutical company developing innovative anti-cancer drugs in the field of epigenetics, recently received an additional investment from Merck Serono Ventures...
Trustpilot, an Åbyhøj, Denmark-based operator of a consumer website where users can gain an overview of companies’ customer satisfaction and contribute their own experiences,...
Symphogen, a Copenhagen, Denmark-based biopharmaceutical company developing superior antibody therapeutics to treat cancer, infectious and autoimmune diseases, closed a €100m round of financing. The...
